Brefeldin A
- 布雷菲德菌素a; Cyanein; Decumbin; Nectrolide; BFA; Synergisidin
货号: abs810012
货号-规格 | 货期 | 价格 | 数量 |
abs810012-10mg | 现货 | ¥772.00 | - + |
abs810012-25mg | 现货 | ¥1764.00 | - + |

产品描述 | ||
描述 | 布雷菲德菌素A(BrefeldinA)是一种内酯抗生素和ATPase抑制剂,作用于蛋白质转运,在HCT 116细胞中IC50为0.2μM,诱导癌细胞分化和凋亡。BrefeldinA是一种真菌代谢产物,抑制内质网和高尔基体之间的传输,BrefeldinA导致膜蛋白分布受损。BrefeldinA作用于肿瘤细胞,主要通过诱导分化和凋亡而发挥其细胞毒性作用。 | |
纯度 | HPLC>98% | |
储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. | |
基本信息 | ||
别名 | 布雷菲德菌素a; Cyanein; Decumbin; Nectrolide; BFA; Synergisidin | |
外观 | 白色或类白色粉末 | |
可溶性/溶解性 | DMSO : 14 mg/mL (50 mM) Ethanol : 2.8 mg/mL (10 mM) | |
生物活性 | ||
靶点 | ATPase (HCT 116) | |
In vitro(体外研究) | Brefeldin A is a fungal metabolite and blocks the forward transport between the endoplasmic reticulum and Golgi apparatus, Brefeldin A causes an impaired distribution of the membrane proteins. When HCT 116 human colon cancer cell is treated with Brefeldin A, morphological changes indicating cell differentiation are observed. Brefeldin A exerts its cytotoxic effects mainly by inducing differentiation and apoptosis in tumor cells. The treatment of the strips with 20 μg/mL Brefeldin A for 6 hours completely abolishes the relaxation induced by bradykinin in the presence of 10mM indomethacin and 30 μM L-NOARG. The treatment with 20 μg/mL Brefeldin A substantially abolishes the bradykinin-induced decreases in i and tension in the range of concentrations between 1 nM and 1 mM. Brefeldin A has no effect on the i elevation in endothelial cells induced by bradykinin or substance P. Addition of the fungal metabolite Brefeldin A does not affect the spontaneous phospholipid-dependent GTPS binding to myr-rARF1 but totally abolishs the retinal isotonic extract (RIE)-catalyzed exchange, with half-maximal inhibition at 2 μM Brefeldin A. Brefeldin A prevents a wide variety of membrane traffic pathways. Brefeldin A inhibits an ADP-ribosylation factor-specific guanine nucleotide exchange activity present in Golgi membranes or in brain cytosol. The complete prevention by Brefeldin A strongly suggests that the retinal extract contains an ARF-specific guanine nucleotide exchange factor. Retinal isotonic extract (RIE)-catalyzed GTPS release from both ADP-ribosylation factors (ARFs) is only partly inhibited by Brefeldin A, even at 300 μM. Brefeldin A induces fusion of the Golgi apparatus with the ER. Brefeldin A abolishes the inhibitory effect of the CERT inhibitor HPA-12. Brefeldin A treatment, which induces fusion of the Golgi apparatus and the ER, rescues the limonoid-induced prevention of sphingomyelin biosynthesis. BFA treatment of CHO cells causes a 2 to 3 fold increase in sphingomyelin synthesis. Apart from B-CLL cells, Brefeldin A reportedly causes apoptosis in multiple myeloma (U266, NCI-H929), Jurkat, HeLa, leukaemia (HL60, K562, BJAB), colon (HT-29) and prostate, as well as adenoid cystic sarcoma cells. The administration of 25 ng/mL of Brefeldin A completely blocks growth of HF4.9 and HF28RA cells, whereas higher Brefeldin A doses (75 ng/mL) are required to achieve the same effect in HF1A3 cells. Cell proliferation is inhibited within 24 hours in a dose-dependent manner and, depending on the cell line, almost complete cessation of 3H-thymdine incorporation is observed at 50-75 ng/mL of Brefeldin A (26%, 76%, 87% inhibition at 50 ng/ml and 75%, 87%, 92% inhibition at 75 ng/mL for HF1A3, HF4.9 and HF28RA cells respectively. Brefeldin A-induced cell killing is in a dose-dependent manner using YO-PRO 1/PI assay. Brefeldin A could improve the HDR(homology-directed repair) efficiency. It is an enhancer of CRISPR-mediated HDR. | |
参考文献 | ||
参考文献 | [1] Zhu JW, et al. Bioorg Med Chem. 2000, 8(2), 455-463.
[2] Ohnishi Y, et al. Br J Pharmacol. 2001, 134(1), 168-178. [3] Franco M, et al. J Biol Chem. 1996, 271(3), 1573-1578. [4] Hullin-Matsuda F, et al. J Biol Chem. 2012. [5] Wlodkowic D, et al. Leuk Res. 2007, 31(12), 1687-1700. | |
温馨提示:本产品仅作科研实验使用,不支持临床等研究 |
- 实验方法 实验条件
共 0张,还能上传 8张 提交
- 提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要提问”按钮填写您的疑问。
提交不成功?请联系info@absin.cn。
- A Novel PD-L1-Containing MSLN Targeting Vaccine Elicits Therapeutic Antitumor Immunity in Mice
Wuyi Zeng, Jiayi Pan, Maoping Huang, Zixuan Fang, Jiangtao Jia, Jun Dong, Rong Zhang, Menghua He, Hanyu Zhong, Jiashan He, Xinyu Yang, Yi Shi,Danni Wang, Jun Zeng, Bishi Fu, Bei Zhong, Hui Liu
research square. 2022 Apr 15 .
- Cysticercus cellulosae Regulates T-Cell Responses and Interacts With the Host Immune System by Excreting and Secreting Antigens
Xianmin Fan, Yue Zhang, Renhui Ouyang, Bo Luo, Lizhu Li, Wei He, Meichen Liu, Nan Jiang, Fengjiao Yang, Lingjun Wang, Biying Zhou
Front Cell Infect Microbiol.. 2021 Sep 03 .
影响因子: 5.293
促销资讯 更多
订购信息
您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。